The intraoperative imaging systems segment is expected to hold the largest of the market in 2016
By component, the intraoperative imaging systems segment accounted for the largest share of the market. The large share of this segment can primarily be attributed to factors such as significant installation costs associated with diagnostic imaging products, increasing installation of hybrid ORs across major countries, ongoing integration and automation of OR workflows, and continuous technological advancements in the field of diagnostic imaging.
By application, the thoracic segment is expected to be the fastest growing segment in the forecast period
The thoracic segment is expected to grow at the fastest CAGR. Growth of this segment can be attributed to the rising number of thoracic surgeries across the globe coupled with growing awareness of healthcare professionals towards the cost & therapeutic efficacy offered by hybrid ORs is expected to drive the growth of this segment during the forecast period.
North America dominated the market in 2016
Geographically, the hybrid operating room market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World. North America accounted for the largest share of the market in 2016, followed by Europe. The large share of North America in this market can primarily be attributed to the significant investments by hospitals to upgrade their operating rooms, coupled with the increasing number of surgical procedures and ambulatory surgery centers in the region.
As of 2016, the major product manufacturers operating in the global hybrid operating room market included Philips Healthcare (The Netherlands), Siemens Healthineers (Germany), Stryker Corporation (U.S.), Toshiba Corporation (Japan), GE Healthcare (U.S.), IMRIS Inc. (U.S.), Eschmann Equipment (U.K.), MAQUET GmbH (Germany), Trumpf Medical (Germany), and Skytron LLC (U.S.), among others
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
